Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad-HGF intramyocardial injection during CABG for ischemic heart disease
ChiCTR-TRC-14004898Phase 4Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jul 2014
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
Phase 4 trial of adenovirus-hepatocyte growth factor in coronary arteriosclerosis (3 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Heart function, Myocardial perfusion/metabolism and 1 more. Started Jul 2014; status: recruiting.
02
Drugs
adenovirus-hepatocyte growth factor
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-14004898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004898.